Contributors -- Preface -- 1 HSP27 as a Therapeutic Target of Novel Inhibitors and Dietary Phytochemicals in Cancer -- 2 Heat Shock Protein 27 (HSP27, HSPB1) is Up-Regulated by Targeted Agents and Confers Resistance to Both Targeted Drugs and Chemotherapeutics -- 3 Heat Shock Proteins and Cancer: Plant Based Therapy -- 4 Chaperonotherapy for Alzheimer's Disease: Focusing on HSP60 -- 5 Secreted and Circulating Cell Stress Proteins in the Periodontal Diseases -- 6 The Role of Heat Shock Protein 70 in Infection and Immunity -- 7 Potential Cytoprotective Effects of Heat Shock Proteins to Skeletal Muscle -- 8 Heat Shock Proteins in Triple-Negative Breast Cancer (TNBC) Treatment -- 9 Heat Shock Proteins in Multiple Sclerosis Pathogenesis: Friend or Foe? -- 10 New Indications for HSP90 and HSP70 Inhibitors as Antiviral Drugs -- 11 Potential Applications of Nanoparticles for Hyperthermia -- 12 Gene Therapy Against HSP90: Glucocorticoid Receptor-Assisted Cancer Treatment -- 13 Potential of HSP90 Inhibitors to Treat Neurofibromatosis-Related Tumors -- 14 Role of Heat Shock Protein 90 in the Cause of Various Diseases: A Potential Therapeutic Target -- 15 HSP90 Inhibitor-Based Strategies for Cancer Therapy: Advancing Toward Clinical Impact -- 16 Molecular Survival Strategies of Organisms: HSP and Small Molecules for Diagnostics and Drug Development.-17 Targeting Heat Shock Proteins in Colorectal Cancer -- Index.